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Although Apc is well characterized as a tumor-suppres-
sor gene in the intestine, the precise mechanism of this
suppression remains to be defined. Using a novel induc-
ible Ahcre transgenic line in conjunction with a loxP-
flanked Apc allele we, show that loss of Apc acutely
activates Wnt signaling through the nuclear accumula-
tion of -catenin. Coincidentally, it perturbs differentia-
tion, migration, proliferation, and apoptosis, such that
Apc-deficient cells maintain a “crypt progenitor-like”
phenotype. Critically, for the first time we confirm a
series of Wnt target molecules in an in vivo setting and
also identify a series of new candidate targets within the
same setting.
Supplemental material is available at http://www.genesdev.org.
Received October 3, 2003; revised version accepted April 19,
2004.
The APC gene encodes the adenomatous polyposis coli
tumor-suppressor protein, the germline mutation of
which characterizes Familial Adenomatous Polyposis
(FAP), an autosomal syndrome characterized by multiple
colorectal lesions (Kinzler et al. 1991). Inactivation of
APC is also recognized as a key early event in the devel-
opment of sporadic colorectal cancers. By targeting
-catenin for degradation and thereby regulating Wnt
signaling (Kinzler and Vogelstein 1996; Morin et al.
1997) APC has been implicated in a range of cellular
functions including adhesion, apoptosis, and cell cycle
control (Bienz and Clevers 2000). APC may also have a
Wnt-independent role in cell migration and chromo-
somal stability (Näthke et al. 1996; Fodde et al. 2001;
Kaplan et al. 2001). However, the phenotype accompa-
nying loss of APC appears to be context dependent, with
different consequences in different cell types and at dif-
ferent stages of neoplastic progression (e.g., Gallagher et
al. 2002; Harada et al. 2002). Hence, the role of APC in
normal intestinal epithelium and the primary conse-
quences of its loss are not known, and as a consequence,
neither is the precise sequence of events (both molecular
and cellular) arising from its loss to the development of
overt preneoplastic lesions.
Cell renewal within the intestinal epithelium is
highly regulated and position dependent. Absorptive
cells generated within intestinal crypts migrate upward
until they either die by apoptosis or are shed into the gut
lumen, a process that takes 3–5 d (Potten et al. 1997). A
central role for Apc in controlling this process has been
suggested by two recent studies. First, blockade of Wnt
signaling in cultured cells has been used to implicate
normal Wnt signaling in imposing a crypt progenitor
phenotype (van de Wetering et al. 2002). Second, Wnt
signaling has been shown to influence paneth cell posi-
tioning in the crypt through transcriptional activation of
EphB2 and EphB3 (Batlle et al. 2002). Furthermore, a role
for Apc in cell migration has been suggested based on its
complex association with, and effect on, cytoskeletal
proteins.
Here, for the first time, we determine the immediate
consequences of Apc loss in otherwise normal murine
epithelium. Inactivation of Apc leads to the rapid
nuclear relocalization of -catenin, a coincident gross
change in the transcriptome, and a coordinated series of
cellular changes, including failure to migrate and differ-
entiate. Together, these effects allow evasion of the nor-
mal ablative fate.
Results and Discussion
Loss of Apc perturbs intestinal pathology
and causes morbidity after 5 d
To investigate the phenotype of conditional deletion of
Apc, mice bearing a lox-flanked Apc allele were crossed
onto a novel inducible cre transgenic background, which
uses the Cyp1A promoter to deliver inducible cre ex-
pression in the intestine (details of this AhCre transgene
are given in Supplementary Fig. 1). Cre+Apcfl/fl and
Cre+Apc+/+ progeny were identified and were subjected
to four daily injections of -napthoflavone at 8–10 wk of
age, resulting in virtually 100% intestinal recombina-
tion as scored through the Rosa26R allele (Supplemen-
tary Fig. 1). On day 5, Cre+Apcfl/fl mice became visibly ill
and were killed. In contrast, Cre+Apc+/+ mice showed no
symptoms of illness.
Histological analysis of the organs from the napthofla-
vone-induced Cre+Apcfl/fl mice revealed altered crypt–
villus architecture such that a discrete crypt was no
longer identifiable, but morphologically atypical “crypt-
like” cells now occupied the majority of the crypt–villus
axis (Fig. 1a,b). Cells were more densely packed than in
control mice, and the upper extent of phenotypic change
was readily identifiable from hematoxylin-and-eosin-
stained material (Fig. 1a,b). To confirm that the pattern
of atypical histology was coincident with the pattern of
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Apc inactivation, sections were stained for Apc expres-
sion (Fig. 1c,d). In induced Cre+Apcfl/fl mice, the pattern
of loss of Apc directly overlaid the pattern of histological
change. Analysis of Cre+Apc+/+ mice additionally trans-
genic for the Rosa26R reporter locus confirmed that 5 d
is a sufficient period for repopulation of the entire crypt–
villus axis by wild-type cells (Fig. 1e). In contrast, com-
plete repopulation did not occur in Cre+Apcfl/flRosa26R
mice, as evidenced by the pattern of -galactosidase
staining, which directly overlay the aberrant crypt pa-
thology and excluded the retained unrecombined villus
(Fig. 1f,g). This demonstrates both aberrant repopulation
of the crypt–villus axis by Apc deficient cells and failure
of the normal process of villus cell removal.
Loss of Apc alters the normal pattern of differentiation
and proliferation
We next examined how loss of Apc had perturbed differ-
entiation using a number of histological markers (Fig. 2).
Apc-deficient cells were no longer capable of expressing
the villus cell markers alkaline phosphatase (Fig. 2a,b) or
Villin (Supplementary Fig. 2). Figure 2d shows that Gob-
let cells are lost in the absence of Apc and that no bind-
ing is observed for the Pokeweed lectin. Despite this lat-
ter observation, lysozyme staining did identify Paneth
cells, but these were now distributed throughout the
crypt-like area, rather than being confined to their nor-
mal position at the crypt base (Fig. 2f). These observa-
tions therefore reflect perturbed positioning
and also possibly perturbed differentiation
of the Paneth cells. Notably, the distribu-
tion of these Paneth-like cells directly par-
allels that observed in EphB3−/− mice
(Batlle et al. 2002) and is presumably a con-
sequence of alterations in the EphB gradi-
ent. We also evaluated the relative propor-
tion of enteroendocrine cells, finding them
to be reduced in the aberrant areas (Supple-
mentary Fig. 2; 1.5% in control crypts com-
pared with 0.8% in induced Cre+Apcfl/fl
crypts, p = 0.04, Mann Whitney U test).
Changes were also observed in the ex-
pression patterns of a number of extracellu-
lar matrix proteins, including laminin 1
and 2, laminin 2, tenascin, and perlecan
(Supplementary Fig. 2). These findings indi-
cate that loss of Apc in the epithelium also
has an immediate effect on the surrounding
mesenchyme.
Previous studies have characterized a de-
fined proliferative zone within the normal
crypt. To test whether this zone was al-
tered, mice were injected with BrdU and
killed 2 h later (Fig. 3a,c). The location and
proportion of cells in S phase was then
scored. In control mice, cycling cells were
confined to the expected mid crypt region
(Fig. 3a,e). However, induced Cre+Apcfl/fl
crypts showed a 45% increase in the prolif-
eration index (Cre+Apc+/+ crypts 23.6% ±
2.3% standard error, Cre+Apcfl/fl crypts
34.4% ± 2.0%, p = 0.04, Mann Whitney,
n = 3), with proliferation now occurring in-
dependently of position (Fig. 3c,f). Staining
with Mcm2 antibody further supported
these observations, as it marked an expanded zone of
proliferative competence in the mutants (Fig. 2g,h).
Apc deficiency abrogates migration
We next tracked the pattern of migration of BrdU-labeled
cells by killing mice 24 h after BrdU exposure (BrdU is
bioavailable for <2 h, effectively “tagging” those cells in
S phase; Fig. 3b,d). In induced Cre+Apc+/+ mice, the av-
erage distance of BrdU-positive cells from the base of the
crypt increased by 60 µm at 24 h (control average dis-
tance at 2 h, 32.73 µm ± 3.31 µm S.E., and at 24 h, 98.64
µm ± 3.49 µm; Cre+Apcfl/fl mice at 2 h, 92.3 µm ± 11.56
µm, and at 24 h, 92.86 µm ± 7.41 µm). In the induced
Cre+Apcfl/fl mice, the average value did not change, nor
did the cumulative distribution of labeled nuclei (Fig. 3f).
We therefore show that inactivation of Apc com-
pletely abrogates migration along the crypt–villus axis.
This change provides a ready mechanism both for the
selective retention of somatically arising Apc mutant
cells and for the acquisition of further genetic changes. It
is, however, clear that the effect of Apc deficiency ex-
tends beyond migration, as deficiency also leads to the
production of daughter cells that have many properties
of premalignant cells, including both failed differentia-
tion and increased proliferation.
The changes observed in proliferation were accompa-
nied by enhanced levels of cell death, with elevated lev-
els of apoptosis in the Cre+Apcfl/fl mice either scored
Figure 1. Changes in intestinal crypt pathology 5 d after the first injection of the
cre-inducing agent -napthoflavone. (a,b). Hematoxylin-and-eosin-stained sections for
control, induced Cre+Apc+/+ (a), and induced Cre+Apcfl/fl (b) mice, showing an enlarged
crypt-like region in the induced Cre+Apcfl/fl mice. (c,d) Apc immunofluorescence in
induced Cre+Apc+/+ (c) and in induced Cre+Apcfl/fl (d) mice. Loss of Apc protein was
observed in all morphologically atypical cells (below the arrow) in Cre+Apcfl/fl mice.
Apc staining was observed in unrecombined morphologically normal cells in the villus
(above the arrow). (e,f) Wholemount preparations of intestines stained for lacZ activity
to report cre-mediated recombination at the Rosa26R locus. Recombined control cells
completely repopulate the crypt–villus axis (e) but fail to do so in the absence of Apc (f).
(g) Sectioned material from f confirming that the pattern of recombination scored by
LacZ activity directly overlays the pattern of histological change. Note that the staining
for -galactosidase exactly complements the Apc staining, with only the morphologi-
cally atypical cells (below the arrows) staining for -galactosidase. For all panels, arrows
indicate the point of demarcation between normal and atypical histology.
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histologically (control crypts, 3.5% ± 0.45%
S.E.; Cre+Apcfl/fl, 11.1% ± 1.2; p = 0.01, Mann
Whitney, n = 5) or identified immunohisto-
chemically with an antibody against active
caspase-3 (Fig. 3g,h). These findings contrast
with previous studies (Bedi et al. 1995) that
have reported reduced levels of apoptosis in
colorectal cancer. This is presumably a reflec-
tion of our focus on the primary consequences
of Apc loss within a naive epithelium, rather
than on the adapted behavior of a neoplastic
population. There appear three possible expla-
nations for the increase we observe in apopto-
sis. First, this may be a direct consequence of
c-Myc up-regulation in a manner analogous to
that demonstrated in pancreatic  cells (Pelen-
garis et al. 2002). Second, this may result from
altered matrix interactions that subsequently
stimulate an anoikis signal. In support of this,
we see changes in the patterns of expression of
many of the laminins, of MMP7, and of the
antiadhesive molecule tenascin (Probstmeier
et al. 1990). Third, mitosis may be aberrant, as
Apc has been implicated in the formation of
mitotic spindles (Fodde et al. 2001; Kaplan et
al. 2001). Indeed, many of the apoptotic figures
we observed were large, a phenomenon previ-
ously interpreted to reflect death of 4N cells at
a G2/M checkpoint (Merritt et al. 1997).
Elevated apoptosis and enhanced prolifera-
tion have been described previously in studies
that have altered -catenin/TCF4 signaling in
intestinal epithelium (Wong et al. 1998, 2002).
However, the changes we identify are far more
extensive, including, in addition, gross changes
in differentiation and migration. The enhanced
perturbation associated with Apc loss may reflect
differences in the timing, extent, or localization
of -catenin up-regulation or, indeed, -catenin
independent effects.
Loss of Apc leads to rapid nuclear localization
of -catenin and allows identification of Wnt
targets in an in vivo setting
We next investigated -catenin levels within the
Cre+Apcfl/fl tissue at day 5. There was no increase
in total -catenin in the Cre+Apcfl/fl samples
(Fig. 4a). However, levels of dephosphorylated
-catenin were moderately elevated and, cru-
cially, -catenin relocalized to the nuclei in the
Cre+Apcfl/fl tissue (Fig. 4c; Supplementary Fig. 3).
To more precisely define the time scale of nuclear
relocalization, immunohistochemical analyses
were also performed at days 1, 2, 3, and 4 follow-
ing induction of the cre recombinase (Supplemen-
tary Fig. 3). This analysis showed that relocaliza-
tion occurred at day 3, and this was coincident
with the observed onset of changes in morphol-
ogy, proliferation, and apoptosis.
To test whether nuclear -catenin was activat-
ing transcription of its known target genes, mi-
croarray analysis was performed using the af-
Figure 3. Altered proliferation, migration, and apoptosis in the absence of Apc.
(a–f) BrdU staining in control and Apc-deficient intestinal epithelium. (a) BrdU-
positivite cells in wild-type-induced Cre+Apc+/+ crypts 2 h following BrdU injection
are confined to a proliferative zone within the crypt. (b) The position of BrdU-
positive cells in crypt–villus axis of control, induced Cre+Apc+/+ mice 24 h after
BrdU injection, indicating migration of labeled cells onto the villus. (c) BrdU stain-
ing in induced Cre+Apcfl/fl epithelium 2 h after BrdU injection show that positively
stained cells are present throughout the entire aberrant crypt-like structure. (d)
BrdU staining 24 h after injection of BrdU in induced Cre+Apcfl/fl intestinal epithe-
lium. (e) Position of BrdU-positive cells within the control crypt–villus axis at 2 h
(black bars) and 24 h (open bars). Position 0 represents the base of the crypt. Note the
increase in position at 24 h, reflecting migration. (f) Position of BrdU cells within the
crypt-like structure in induced Cre+Apcfl/fl mice at 2 h (black bars) and 24 h (open
bars). Unlike in the controls, no migration of labeled cells is evident. (g,h) Increased
apoptosis in Apc mutant crypts. Immunohistochemical staining of active caspase 3
in induced Cre+Apc+/+ mice (g) and induced Cre+Apcfl/fl mutant crypts (h). This
staining confirmed apoptosis counts from H&E-stained sections that showed sig-
nificantly increased apoptosis in Apc deficient crypts (11.1% ± 1.2%) compared
with control crypts (3.5% ± 0.45%; p = 0.01; Mann Whitney, n = 5).
Figure 2. Perturbation of differentiation in the absence of Apc. (a,b) Immuno-
histochemical staining for alkaline phosphatase in control, induced Cre+Apc+/+
mice (a) and induced Cre+Apcfl/fl intestines (b). Apc mutant cells do not express
the villus marker alkaline phosphatase, with the arrow indicating demarcation
between the residual wild-type and recombined Apc-deficient cells. (c,d) Stain-
ing for Goblet cells (blue cells stained with alcian blue) and Paneth cells (red
cells stained with Pokeweed lectin) in the crypt–villus axis of control induced
Cre+Apc+/+ mice (c) and induced Cre+Apcfl/fl intestines (d). Insets show detail of
crypts. No Goblet or Paneth cell staining was observed in the induced Cre+Apcfl/fl
mice. (e,f) Staining for lysozyme in induced Cre+Apc+/+ (e) and induced
Cre+Apcfl/fl (f) mice. Lyzozyme positivity is confined to the base of the crypt in
the controls but is distributed throughout the crypt-like region in the induced
Cre+Apcfl/fl mice. (g,h) Mcm2 staining with positivity restricted to the crypt
within the induced Cre+Apc+/+ mice (g) but extending through the aberrant crypt
structure in the induced Cre+Apcfl/fl mice (h).
Loss of Apc in vivo
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fymetrix U74A chip. RNA samples were derived from
sibling Cre+Apcfl/fl and Cre+Apc+/+ mice given four daily
injections of -napthoflavone and killed at days 4 and 5.
The most significantly up- and down-regulated genes
identified by SAM analysis at day 5 are shown in Supple-
mentary Figure 4. Of the 100 most significantly up-regu-
lated genes, 10 have been previously associated with
Wnt signaling (either directly or through recent arrays
that had examined targets of the -catenin/TCF4 com-
plex).
At the earlier 4-d timepoint, array analysis was per-
formed using the larger MOE430A Affymetrix chipset
(Supplementary Table 1). Of the comparable genes up-
regulated at day 5, 45 of 47 showed increases, of which
36 were in excess of twofold. These 36 included c-Myc,
CD44, Tiam 1, Sema3c, and EphB3, all of which were
confirmed changes at day 5. These data are, therefore,
consistent with the notion that these are important early
changes following nuclear relocalization of -catenin.
Use of the larger chip set also revealed up-regulation of
other Wnt target genes at day 4, including Sox17 and
Axin2 (Lustig et al. 2002).
To validate the results obtained from the microarray
analysis, we examined the expression pattern of a subset
of dysregulated genes. Up-regulation of
CD44, C-Myc, laminin 2, EphB2, and
EphB3 was confirmed immunohistochemi-
cally in the Apc-deficient tissue (Figs. 4d–g,
5a–d; Supplementary Fig. 2). Expression of
the EphrinB2 ligand, which is normally re-
stricted to the top of the crypts and villi
(Fig. 5f), was reduced in concordance with
the reduction in villus differentiation in the
Cre+Apcfl/fl tissue (Fig. 5g). These data
therefore confirm, in an in vivo setting,
many of the targets of Wnt signaling that
have been implicated from in vitro studies
(e.g., Bienz and Clevers 2000; van de Weter-
ing et al. 2002). These include up-regulation
of CD44, c-Myc, MMP-7 (matrilysin), -2
laminin, Sema3c (confirmed by RT–PCR;
Supplementary Fig. 4) Ets-2, EphB2, EphB3,
and GPR49. The array analysis also indi-
cated up-regulation of a series of genes that
either interact with CD44 or are targets of
CD44. These include MMP-7, TIAM1,
FGF4 and its receptor, and TASR-2. The up-
regulation of TIAM1 (confirmed by RT–
PCR; Supplementary Fig. 4) is particularly
interesting, as TIAM1 has been shown to
mediate Ras signaling. Indeed, mice defi-
cient in TIAM1 are resistant to Ras-induced
skin tumors (Malliri et al. 2002).
Batlle et al. (2002) have shown that defi-
ciency of EphB3 leads to abnormal Paneth
cell positioning in the crypt. We show here
that Wnt-mediated up-regulation of EphB3
yields a similar Paneth cell phenotype, con-
firming a pivotal role for the EphB/ephrinB
mutual repulsion system in defining crypt–
villus architecture. Our results are also con-
sistent with the notion that Apc mutant
cells express the same genetic program as
cells at positions 1–2 of the crypt (van de
Wetering et al. 2002), with notable in-
creases in EphB3, MMP7, and Pla2g2a being
characteristic of both Paneth cells (Stappenbeck et al.
2003) and the Apc-deficient cells described here.
In summary, we have shown that Apc is a critical de-
terminant of cell fate in the murine small intestinal epi-
thelium. Acute activation of Wnt signaling immediately
produces many of the phenotypes associated with early
colorectal lesions: failed differentiation, increased prolif-
eration, and aberrant migration. Within a short time
scale, multiple processes are affected: interactions with
the cellular matrix, interactions with the basement
membrane, increased proliferation, and failure of posi-
tional cues (EphB/ephrinB).
At present, many different strategies are being pursued
to identify the genes controlled by Wnt signaling. How-
ever, these models are necessarily constrained by the ex-
perimental systems used. For example, analysis of Wnt
blockade within immortalized cells might not be pre-
dicted to precisely model active Wnt signaling in a physi-
ological setting. The ability to acutely activate Wnt sig-
naling in normal epithelial cells has allowed us for the
first time to examine many of the proposed targets of
Wnt signaling in vivo. Remarkably, given the diverse
nature of the models studied, we can validate virtually
all the previously reported Wnt targets in an in vivo set-
Figure 4. (a) Immunoblasts show the levels of Apc, -catenin, and dephosphorylated
-catenin. Equal amounts of protein from induced control Cre+Apc+/+, uninduced
Cre+Apcfl/fl, and induced Cre+Apcfl/fl mice were separated on a 4%–12% gradient gel
and probed with antibodies against Apc, -catenin, actin, and dephospho--catenin as
shown. Probing with dephospho--catenin was performed first and the blot stripped
before it was reprobed with the antibody that detects all -catenin so that these two
images reflect identical samples. No image processing was performed on the films, and
they are shown in their original appearance. Although the total amount of -catenin is
not grossly different between the different samples, the amount of dephosphorylated
-catenin is increased after inactivation of Apc in the tissue obtained from induced
Cre+Apcfl/fl mice, whereas detectable Apc levels drop significantly. (Lanes 1,2) Induced
Cre+Apc+/+. (Lane 3) Noninduced Cre+Apcfl/fl. (Lanes 4–6) Induced Cre+Apcfl/fl. The
migration of proteins with molecular weights of 220, 160, 120, 100, 90, 80, 60, 50, 40,
30, and 20 kDa (top) and 120, 100, 90 80, and 50 kDa (bottom) are indicated to the left
of the blots. (b,c) Increased nuclear -catenin staining in crypts. (b) -catenin staining
in control crypts 5 d after the first of four inductions with -napthoflavone, showing
nuclear staining confined to the cells at base of the crypts. (c) Nuclear -catenin stain-
ing observed throughout the whole of the aberrant structure in induced Cre+Apcfl/fl
mice 5 d after induction. (d,e) Immunohistochemical confirmation of c-Myc up-regu-
lation. (d) Staining for c-Myc in control Cre+Apc+/+ intestine at day 5. The inset shows
crypt detail; note the absence of nuclear staining. (d) Nuclear up-regulation of c-Myc in
the induced Cre+Apcfl/fl mice, with inset showing crypt detail. (f,g) Immunohistochemi-
cal confirmation of CD44 up-regulation. (f) No detectable CD44 staining in control
Cre+Apc+/+ intestines at day 5. (g) Up-regulation of CD44 in the induced Cre+Apcfl/fl
mice. The inset shows detail.
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ting. Furthermore, we have been able to use our in vivo
approach to identify many novel Wnt candidate target
genes.
We have, therefore, identified a number of molecules
that can be used as markers for loss of Apc and that thus
represent potential targets for chemoprevention. Given
our improved understanding of the role played by Apc in
defining the normal differentiation and growth programs
within the intestine, the challenge now is to determine
how this data can be used for therapeutic and diagnostic
purposes.
Materials and methods
Mouse colony
All experiments were performed according to UK Home Office regula-
tions. Ahcre-positive mice were intercrossed with mice carrying a LoxP
flanked Apc allele: Apc580s (Shibata et al. 1997) and the Rosa26R reporter
allele. Progeny from this cross were intercrossed to derive an outbred
colony, segregating for the C57BL6/J, 129/Ola, and C3H genomes at a
ratio of 75%, 12.5%, and 12.5%, respectively.
RT–PCR
RT–PCRs for Cre, Eb2, Sema3c, Pla2g2a, and TIAM1 were performed
using the approach shown in Supplemental Material. Tissues were snap
frozen, and RNA was extracted using the TRIzol method (Gibco).
-Galactosidase analysis
To determine the pattern of recombination at the Rosa26R reporter lo-
cus, both whole mounts and sectioned material were analyzed as previ-
ously described (Ireland et al. 2004; see also Supplemental Material)
Tissue isolation
To induce recombination, mice were given daily intraperitoneal injec-
tions of -napthoflavone (80 mg/kg). At each time point, mice were killed
and the small intestine removed and flushed with water. Intestines were
dissected as follows: The proximal 7 cm was mounted en face, fixed
overnight in methacarn (methanol, chloroform, and acetic acid; 4:2:1
ratio), and paraffin embedded. The following 3 cm was opened and placed
into RNA later (Sigma), ensuring that all mesentery and Peyers patches
were removed. The following 5 cm was divided into 1-cm lengths,
bundled using surgical tape, and then fixed in 4% formaldehyde at 4°C
for no more than 24 h before processing. Samples for Western analysis,
frozen sections, and electron microscopy were then taken from the next
5 cm of intestine, and the remainder was fixed in methacarn.
Assaying apoptosis, mitosis, and S-phase labeling in vivo
Apoptosis and mitotic index were scored from hematoxylin-and-eosin-
stained sections as previously described (Merritt et al. 1997). Apoptosis
was independently confirmed by immunohistochemical staining with an
antibody against active caspase 3 (1:750; R&D systems; Marshman et al.
2001). For BrdU labeling, mice were injected with 0.25 mL of BrdU (Am-
ersham), and staining was performed using an anti-BrdU antibody con-
jugate (Roche) at 1 part in 50.
Western analysis and immunohistochemistry
For a detailed description, see Supplemental Material. Immunohisto-
chemistry was performed according to Batlle et al. (2002), Kongkanuntn
et al. (1999), and Van Noort et al. (2002); Western analysis was performed
according to Hinck et al. (1994) and Van Noort et al. (2002).
RNA extraction and array
Eight-week-old male sibling mice were used for the array analysis. Three
centimeters of the small intestine located 7 cm from the stomach was
placed in RNAlater (after removing any mesentery and ensuring that no
Peyers patches were present). The tissue was then homogenized in trizol
reagent and RNA extracted using standard phenol-chloroform method-
ologies. Biotinylated target cRNA was generated according to http://www.
paterson.man.ac.uk/facilities/mbcf/protocols.jsp. Affymetrix Gene Ar-
rays were run at the Cancer Research UK facility at the Paterson Institute
for Cancer Research. Raw signal intensities were initially screened using
the MaxD/View-Program (http://www.bioinf.man.ac.uk/microarray/
maxd/index.html) to remove false-positive and false-negative signals (us-
ing a cutoff of at least one p value for each transcript <0.2). The data was
then normalized by global normalization, again using the MaxD/View-
Program. Data was finally analyzed using the SAM-Program (Tusher et
al. 2001). A  value, which produced a false discovery rate of 5% was used
to define the candidate genes. The output from this analysis therefore
produces a ranked list of genes, of which the probability that each indi-
vidual gene is deregulated is 95%.
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